Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Epihunter has developed a clinically validated digital therapeutic platform that uses wearable EEG headbands and real-time AI to detect absence seizures. The product has been launched commercially in Europe and Australia, with reimbursement achieved in Australia. Clinical validation studies have been published in leading journals. The company continues to expand its technology into additional seizure types and other neurological conditions such as Parkinson’s disease through ongoing collaborations and studies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Epihunter.